v3.26.1
Derivative Instruments
 6 Months Ended
Jun. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments DERIVATIVE INSTRUMENTS
The Company accounts for derivative instruments in accordance with the ASC Topic 815, Derivatives and Hedging ("ASC 815"). These principles require that all derivative instruments be recognized at fair value on each balance sheet date unless they qualify for a scope exclusion as a normal purchase or sales transaction, which is accounted for under the accrual method of accounting. In addition, these principles permit derivative instruments that qualify for hedge accounting to reflect the changes in the fair value of the derivative instruments through earnings or stockholders’ equity as other comprehensive income on a net basis until the hedged item is settled and recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative instrument’s change in fair value is immediately recognized in earnings. As of June 30, 2026 and December 31, 2025, the Company did not have any derivative instruments that it had designated as fair value or cash flow hedges.
The Company is subject to the following currency risks:
Inventory Purchases from Brazilian, Malaysian and Thai Manufacturers—In order to mitigate the currency risk on inventory purchases from its Brazilian, Malaysian and Thai manufacturers, which are settled in Brazilian real ("BRL"), Malaysian ringgit ("MYR") and Thai baht ("THB"), the Company's subsidiary, All Market Singapore Pte. Ltd. ("AMS"), enters into a series of forward currency swaps to buy BRL, MYR and THB.
Intercompany Transactions Between AME and AMS—In order to mitigate the currency risk on intercompany transactions between AME and AMS, AMS enters into foreign currency swaps to sell British pounds ("GBP").
Intercompany Transactions with Canadian Customer and Vendors—In order to mitigate the currency risk on transactions with Canadian customer and vendors, the Company enters into foreign currency swaps to sell Canadian dollars ("CAD").
The notional amount and fair value of all outstanding derivative instruments in the condensed consolidated balance sheets consist of the following at:
June 30, 2026
Derivatives not designated as
hedging instruments under
ASC 815-20		Notional
Amount		Fair
Value 		Balance Sheet Location
Assets
Foreign currency exchange contracts
Receive BRL/sell USD$22,015 $2,254 Derivative assets
Receive USD/pay EUR21,503 527 Derivative assets
Receive USD/pay CAD10,598 159 Derivative assets
Liabilities
Foreign currency exchange contracts
Receive USD/pay GBP$27,846 $(165)Derivative liabilities
Receive THB/sell USD17,142 (956)Derivative liabilities
December 31, 2025
Derivatives not designated as
hedging instruments under
ASC 815-20		Notional
Amount		Fair
Value 		Balance Sheet Location
Assets
Foreign currency exchange contracts
Receive BRL/sell USD$21,769 $543 Derivative assets
Receive THB/sell USD23,620 189 Derivative assets
Liabilities
Foreign currency exchange contracts
Receive USD/pay GBP$39,878 $(854)Derivative liabilities
Receive USD/pay EUR27,531 (324)Derivative liabilities
Receive USD/pay CAD16,043 (329)Derivative liabilities
    
The amount and location of realized and unrealized gains and losses of the derivative instruments in the condensed consolidated statements of operations for the three and six months ended June 30, 2026 and 2025 are as follows:
Three Months Ended June 30,
20262025
Unrealized (loss)/gain on derivative instruments$(233)$1,067 
Foreign currency gain/(loss)
$932 $(1,289)
Six Months Ended June 30,
20262025
Unrealized gain on derivative instruments$2,594 $3,884 
Foreign currency gain/(loss)
$1,542 $(2,621)
The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC Topic 820, Fair Value Measurements ("ASC 820"). In determining fair value, the Company used a market approach and incorporates the assumptions that market participants would use in pricing the asset or liability, including assumptions
about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable internally developed inputs.